project id: TCGA-UVM; case submitter id: TCGA-WC-A883; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.22; rna integrity number: 8.2; age at index: 76; days to birth: -27953; days to death: 241; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1936; year of death: 2012; age at diagnosis: 27953; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIC; ajcc clinical t: T4; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T3c; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 300; days to sample procurement: 0; initial weight: 30.0; portion submitter id: TCGA-WC-A883-01A-12; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 95.0;